| Autor: |
Maráz Anikó, Nagyiványi Krisztián, Balogh Ingrid, Bodoky György, Mangel László Csaba, Küronya Zsófia, Géczi Lajos, Torday László, Dudás Szilvia, Szűcs Miklós, Nagy Zsófia, Hornyák Lajos, Zolcsák Zita, Bassam Ali, Kocsis Judit, Keresztes Tamás, Kullmann Tamás, Máhr Károly, Solymosi Tibor, Papdán Tímea, Szabó Imre, Varga Zoltán, Biró Krisztina |
| Jazyk: |
maďarština |
| Rok vydání: |
2023 |
| Předmět: |
|
| Popis: |
The aim of our analysis was to evaluate the efficacy of cabozantinib in patients with metastatic renal cell carcinoma. Cabozantinib therapy initiated between 01/01/2019 and 31/12/2022 was evaluated based on a retrospective review of data from 14 renal centers in Hungary. The starting dose was 60 or 40 mg. Physical examinations and laboratory tests were performed every 4 weeks and imaging studies 3-monthly. Tumor response was assessed according to RECIST 1.1, and toxicity according to NCI CTCAE 4.0. A total of 230 patient records were evaluated, 201 (87.4%) of them had clear cell RCC. Cabozantinib was administered as third, second and first-line treatment in 48.7%, 38.3% and |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
